ATG16L1 Depletion‐Mediated Activation of the TRAF1 Signaling in Macrophages Aggravates Liver Fibrosis
Mediators of Inflammation · 2024
DOI: 10.1155/mi/8831821 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, 2024. Verfasst von Yufeng Pan und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Signal Transduction, Macrophages, Autophagy-Related Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Hepatic macrophages play an indispensable role in liver pathophysiology, serving as key orchestrators of both liver injury and repair processes. ATG16L1 (autophagy‐related 16 like 1) has emerged as a novel and critical autophagy marker. In macrophages, ATG16L1 assumes a particularly crucial role. The current understanding of how macrophage ATG16L1 regulates liver inflammation in the context of liver fibrosis is unclear.
Methods
This study included clinical patient samples of liver fibrosis and established a murine model with myeloid‐specific Atg16l1 knockout, creating a mouse model of liver fibrosis. Employing RNA sequencing, we sought to elucidate the mechanisms of macrophage ATG16L1 in liver fibrosis by identifying critical signaling pathways. To assess the influence of macrophage ATG16L1 on hepatocyte apoptosis and hepatic stellate cell (HSC) activation, we constructed a dedicated culture system. Ultimately, the introduction of mice with myeloid‐specific Atg16l1 knock‐in substantiated the protective role of myeloid‐specific Atg16l1 against inflammatory signaling, hepatocyte apoptosis, and activation of HSCs.
Results
An upregulation of the ATG16L1 signal was observed in the liver tissues of patients with liver fibrosis and in fibrotic mice, predominantly localized to hepatic macrophages. In Atg16l1 Δ Mφ mice afflicted with liver fibrosis, we detected exacerbated liver damage, evidenced by heightened inflammatory signal expression, increased hepatocyte apoptosis, and enhanced activation of HSCs. The absence of macrophage Atg16l1 was found to result in elevated TNF receptor‐associated factor 1 (TRAF1) signaling, triggering inflammatory activation, intensifying hepatocyte apoptosis, and facilitating HSC activation through the transforming growth factor beta 1 (TGF‐ β 1) signaling. The detrimental effects of macrophage Atg16l1 depletion were demonstrated to be mitigated upon Atg16l1 reintroduction.
Conclusions
This research delved into the mechanisms by which the macrophage ATG16L1 signal influences inflammatory signaling, hepatocyte apoptosis, and activation of HSCs in liver fibrosis. Consequently, it offers theoretical substantiation and an experimental groundwork for the identification of biological targets for therapeutic intervention in liver fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Southeast University, Nanjing, China.
- Hepatobiliary Center, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of General Surgery, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China.
- School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
- Key Laboratory of Liver Transplantation, NHC Key Laboratory of Hepatobiliary Cancers, Chinese Academy of Medical Sciences, Nanjing, China.
- Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Xuzhou Medical University, 99 Huaihai West Road, Xuzhou, China.
ORCID-Profile: Yufeng Pan, Yi Wei, Xinyu Zhan, Qingfa Bu, Zibo Xu, Xiaozhang Xu, Qi Wang, Yuan Liang, Yue Yu, Haoming Zhou, Ling Lu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Pan, Y., Wei, Y., Zhan, X., Bu, Q., Xu, Z., Xu, X., Wang, Q., Liang, Y., Yu, Y., Zhou, H., & Lu, L. (2024). ATG16L1 Depletion‐Mediated Activation of the TRAF1 Signaling in Macrophages Aggravates Liver Fibrosis. Mediators of Inflammation. https://doi.org/10.1155/mi/8831821
Vancouver
Pan Y, Wei Y, Zhan X, Bu Q, Xu Z, Xu X, et al. ATG16L1 Depletion‐Mediated Activation of the TRAF1 Signaling in Macrophages Aggravates Liver Fibrosis. Mediators of Inflammation. 2024. doi:10.1155/mi/8831821
BibTeX
@article{Pan2024,
author = {Pan, Yufeng and Wei, Yi and Zhan, Xinyu and Bu, Qingfa and Xu, Zibo and Xu, Xiaozhang and Wang, Qi and Liang, Yuan and Yu, Yue and Zhou, Haoming and Lu, Ling},
title = {ATG16L1 Depletion‐Mediated Activation of the TRAF1 Signaling in Macrophages Aggravates Liver Fibrosis},
journal = {Mediators of Inflammation},
year = {2024},
doi = {10.1155/mi/8831821}
}
EUVIMED